Stage-dependent association of BDNF and TGF-β1 with lung function in stable COPD

Respiratory Research

Volumn 13, Issue , 2012, Pages

  Stoll, Paul ^a   Wuertemberger, Urs ^a   Bratke, Kai ^a   Zingler, Christiana ^a   Virchow, J Christian ^a   Lommatzsch, Marek ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

BDNF; COPD; Fibrosis; Inflammation; TGF 1

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; CORTICOSTEROID; DOXEPIN; MUSCARINIC RECEPTOR BLOCKING AGENT; OPIPRAMOL; PHOSPHODIESTERASE INHIBITOR; ROFLUMILAST; SEROTONIN; SERTRALINE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SMOKING; SPIROMETRY; THROMBOCYTE; THROMBOCYTE COUNT; BLOOD; CLASSIFICATION; FORCED EXPIRATORY FLOW; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PNEUMONIA;

AGED; BRAIN-DERIVED NEUROTROPHIC FACTOR; FORCED EXPIRATORY FLOW RATES; HUMANS; LUNG; MALE; MIDDLE AGED; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TRANSFORMING GROWTH FACTOR BETA1;

MLCS; MLOWN;

EID: 84870996869     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-13-116     Document Type: Article

References (38)

1. Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev 2009, 18:213-21. 10.1183/09059180.00003609, 20956146.
2. Burgel PR, Bourdin A, Chanez P, Chabot F, Chaouat A, Chinet T, de Blic J, Devillier P, Deschildre A, Didier A, Garcia G, Jebrak G, Laurent F, Morel H, Perez T, Pilette C, Roche N, Tillie-Leblond I, Verbanck S, Dusser D. Update on the roles of distal airways in COPD. Eur Respir Rev 2011, 20:7-22. 10.1183/09059180.10010610, 21357888.
3. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009, 360:2445-54. 10.1056/NEJMra0804752, 19494220.
4. Vogelmeier CF, Wouters EF. Treating the systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2011, 8:376-9. 10.1513/pats.201102-020RM, 21816995.
5. Sköld CM. Remodeling in asthma and COPD-differences and similarities. Clin Respir J 2010, 4(Suppl 1):20-7.
6. Loza MJ, Watt R, Baribaud F, Barnathan ES, Rennard SI. Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease. Respir Res 2012, 13:12. 10.1186/1465-9921-13-12, 3287122, 22300528.
7. Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, Mullerova H, De Souza MM, Vessey R, Celli B. Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 2007, 62:595-601. 10.1136/thx.2006.064428, 2117244, 17356059.
8. Lommatzsch M, Niewerth A, Klotz J, Schulte-Herbrüggen O, Zingler C, Schuff-Werner P, Virchow JC. Platelet and plasma BDNF in lower respiratory tract infections of the adult. Respir Med 2007, 101:1493-9. 10.1016/j.rmed.2007.01.003, 17317133.
9. Lommatzsch M, Schloetcke K, Klotz J, Schuhbaeck K, Zingler D, Zingler C, Schulte-Herbrüggen O, Gill H, Schuff-Werner P, Virchow JC. Brain-derived neurotrophic factor in platelets and airflow limitation in asthma. Am J Respir Crit Care Med 2005, 171:115-20.
10. Aravamudan B, Thompson M, Pabelick C, Prakash YS. Brain-derived neurotrophic factor induces proliferation of human airway smooth muscle cells. J Cell Mol Med 2012, 16:812-23. 10.1111/j.1582-4934.2011.01356.x, 21651720.
11. Kim IY, Kim MM, Kim SJ. Transforming growth factor-beta: biology and clinical relevance. J Biochem Mol Biol 2005, 38:1-8. 10.5483/BMBRep.2005.38.1.001, 15715939.
12. Araya J, Nishimura SL. Fibrogenic reactions in lung disease. Annu Rev Pathol 2010, 5:77-98. 10.1146/annurev.pathol.4.110807.092217, 20078216.
13. Stoll P, Plessow A, Bratke K, Virchow JC, Lommatzsch M. Differential effect of clopidogrel and aspirin on the release of BDNF from platelets. J Neuroimmunol 2011, 238:104-6. 10.1016/j.jneuroim.2011.06.015, 21803431.
14. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, Virchow JC. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005, 26:115-23. 10.1016/j.neurobiolaging.2004.03.002, 15585351.
15. Lommatzsch M, Braun A, Renz H. Neurotrophins in allergic airway dysfunction: what the mouse model is teaching us. Ann N Y Acad Sci 2003, 992:241-9. 10.1111/j.1749-6632.2003.tb03154.x, 12794063.
16. Lommatzsch M, Lindner Y, Edner A, Bratke K, Kuepper M, Virchow JC. Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax 2009, 64:763-9. 10.1136/thx.2008.110916, 2730557, 19237390.
17. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, Sun B, Tandon NN. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002, 87:728-34.
18. Maclay JD, McAllister DA, Johnston S, Raftis J, McGuinnes C, Deans A, Newby DE, Mills NL, MacNee W. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 2011, 66:769-74. 10.1136/thx.2010.157529, 21507906.
19. Johansson MW, Han ST, Gunderson KA, Busse WW, Jarjour NN, Mosher DF. Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma. Am J Respir Crit Care Med 2012, 185:498-507. 10.1164/rccm.201109-1712OC, 22227382.
20. Braun A, Lommatzsch M, Mannsfeldt A, Neuhaus-Steinmetz U, Fischer A, Schnoy N, Lewin GR, Renz H. Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation. Am J Respir Cell Mol Biol 1999, 21:537-46.
21. Braun A, Lommatzsch M, Neuhaus-Steinmetz U, Quarcoo D, Glaab T, McGregor GP, Fischer A, Renz H. Brain-derived neurotrophic factor (BDNF) contributes to neuronal dysfunction in a model of allergic airway inflammation. Br J Pharmacol 2004, 141:431-40. 10.1038/sj.bjp.0705638, 1574219, 14718253.
22. Johnston SL, Edwards MR. Mechanisms of adverse effects of β-agonists in asthma. Thorax 2009, 64:739-41. 10.1136/thx.2009.119230, 19717707.
23. Lommatzsch M, Klotz J, Virchow JC. Postnatal dexamethasone for lung disease of prematurity. N Engl J Med 2004, 350:2715-8.
24. Wang Q, Lin Y, Zhang Q, Sun SQ, Ling XF. Changes of BDNF expression in hippocampus and serum of rats with artificial chronic obstructive pulmonary disease. Sheng Li Xue Bao 2011, 63:505-10.
25. Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012, 64:238-58. 10.1124/pr.111.005108, 22407616.
26. Itoh T, Tokumura M, Abe K. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. Eur J Pharmacol 2004, 498:135-42. 10.1016/j.ejphar.2004.07.084, 15363987.
27. DeMarch Z, Giampà C, Patassini S, Bernardi G, Fusco FR. Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease. Neurobiol Dis 2008, 30:375-87. 10.1016/j.nbd.2008.02.010, 18424161.
28. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-53. 10.1056/NEJMoa032158, 15215480.
29. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry 2010, 25:1209-21. 10.1002/gps.2463, 20033905.
30. Kenyon NJ, Ward RW, McGrew G, Last JA. TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax 2003, 58:772-7. 10.1136/thorax.58.9.772, 1746790, 12947136.
31. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, Okada Y, Yamasawa F, Nakahara K, Umeda A. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001, 163:1476-83.
32. Soltani A, Sohal SS, Reid D, Weston S, Wood-Baker R, Walters EH. Vessel-Associated Transforming Growth Factor-Beta1 (TGF-β1) Is Increased in the Bronchial Reticular Basement Membrane in COPD and Normal Smokers. PLoS One 2012, 7:e39736. 10.1371/journal.pone.0039736, 3387255, 22768115.
33. Hersh CP, DeMeo DL, Silverman EK. National Emphysema Treatment Trial state of the art: genetics of emphysema. Proc Am Thorac Soc 2008, 5:486-93. 10.1513/pats.200706-078ET, 2645324, 18453360.
34. Ito M, Hanaoka M, Droma Y, Hatayama O, Sato E, Katsuyama Y, Fujimoto K, Ota M. The association of transforming growth factor beta 1 gene polymorphisms with the emphysema phenotype of COPD in Japanese. Intern Med 2008, 47:1387-94. 10.2169/internalmedicine.47.1116, 18670143.
35. Lau WK, Chan-Yeung MM, Yip BH, Cheung AH, Ip MS, Mak JC. The role of circulating serotonin in the development of chronic obstructive pulmonary disease. PLoS One 2012, 7:e31617. 10.1371/journal.pone.0031617, 3272036, 22319639.
36. Brusselle GG. Matrix metalloproteinase 12, asthma, and COPD. N Engl J Med 2009, 361:2664-5. 10.1056/NEJMe0910626, 20018962.
37. Postma DS, Kerkhof M, Boezen HM, Koppelman GH. Asthma and chronic obstructive pulmonary disease: common genes, common environments?. Am J Respir Crit Care Med 2011, 183:1588-94. 10.1164/rccm.201011-1796PP, 21297068.
38. Barnes PJ. Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. Am J Respir Crit Care Med 2006, 174:240-3. 10.1164/rccm.2604008, 16864717.